Grade: Research grade

Factory Location: Hangzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

Monthly Production Capacity: hundreds of grams

Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag

Delivery Lead Time: In stock or 2-3weeks

Sample Provided: yes

Payment Terms: T/T

Antimicrobial peptides (AMPs) have become drug candidates for the treatment of gram-negative bacterial infections, endotoxin shock and sepsis, because these peptides not only have the treatment of bacterial infections, endotoxin shock and sepsis, but also have broad-spectrum antibacterial Activity, in addition, it has antibacterial ability, and can bind endotoxin, and then block the release of cytokines stimulated by endotoxin, thus having a therapeutic effect. LL-37 is the only human-derived antimicrobial peptide in the cathelicidin family. There are many studies on LL-37. LL-37 RKS is a sequence of LL-37, which contains 31 amino acids. The molecular structure is relatively small and has better Cell penetration selectivity.LL-37 RKS contains the main functional fragments in antimicrobial peptides. Although the sequences are different, they have similar biological functions. The difference is that the half-life in the organism is different.